JOLT Health Inc. Announces Issuance of Common Shares in Satisfaction of Interest Payments to Promissory Note Holders and Interest Payment to Convertible Debenture Holder
May 25, 2023 21:13 ET
|
Love Pharma
VANCOUVER, BC, CANADA, May 25, 2023 (GLOBE NEWSWIRE) -- Jolt Health Inc. (formerly Love Pharma Inc.) (“Jolt” and or “the Company”) (CSE:JOLT) (FSE: G1Q0) is pleased to announce that pursuant to a...
LOVE PHARMA INC. ANNOUNCES CHANGE OF NAME TO “JOLT HEALTH INC.” AND INCREASED FOCUS ON BIOTECHNOLOGY
May 16, 2023 18:51 ET
|
Love Pharma
VANCOUVER, BC, CANADA, May 16, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is pleased to announce that it has changed its name to “Jolt Health...
LOVE PHARMA TO EVALUATE MINING OPPORTUNITIES
April 05, 2023 16:30 ET
|
Love Pharma
VANCOUVER, BC, CANADA, April 05, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is currently evaluating mining opportunities in the battery component...
LOVE PHARM INC. ANNOUNCES GRANT OF STOCK OPTIONS
April 03, 2023 16:30 ET
|
Love Pharma
VANCOUVER, BC, CANADA, April 03, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is pleased to announce that it has issued a total of 5,035,000 options...